Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Phase 3 data for Retatrutide is expected to clarify whether the 24.2% Phase 2 result is reproducible at scale, potentially making it the most effective single compound in this class
J., Boudreau, A., Wu, D., Atlas, E
These treatments are offered in a supportive, medically supervised environment to ensure both safety and results
DPP4 activity varied between treatment groups at baseline but overall remained decreased from baseline at follow-up in all
Here is what went into this page specifically: I pulled the full text of the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine on May 11, 2025 (DOI: 10.1056/NEJMoa2416394) and cross-referenced it with the Phase 3 TRIUMPH-4 topline readout from Eli Lilly on December 11, 2025
Another meta-analysis of four randomized, placebo-controlled trials found evidence of a reduction in fasting plasma glucose concentration and no improvement of glycated hemoglobin concentration in subjects with type 2 diabetes mellitus supplemented with acetyl-L-carnitine (ALCAR) (44)
US$ 25.97
US$ 23.93
US$ 23.86
US$ 29.80
US$ 28.03
US$ 27.55
